Drugs that may harm bone: Mitigating the risk.
Level V
Where this comes from
- Record sourced from PubMed, PMID 27055202.
- Also identified by DOI 10.3949/ccjm.83a.15066.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glucocorticoids, proton pump inhibitors, selective serotonin reuptake inhibitors (SSRIs), certain antiepileptic drugs, and aromatase inhibitors have significant adverse effects on bone. Healthcare providers should monitor the bone health of patients on these agents, supplement their intake of calcium and vitamin D, encourage weight-bearing exercise, and initiate osteoporosis-prevention treatment as indicated.
Medical subject headings
- Anticonvulsants
- Aromatase Inhibitors
- Bone Density
- Glucocorticoids
- Proton Pump Inhibitors
- Selective Serotonin Reuptake Inhibitors